SE8505048D0 - Nutritionsemulsion med syretransporterande egenskaper - Google Patents

Nutritionsemulsion med syretransporterande egenskaper

Info

Publication number
SE8505048D0
SE8505048D0 SE8505048A SE8505048A SE8505048D0 SE 8505048 D0 SE8505048 D0 SE 8505048D0 SE 8505048 A SE8505048 A SE 8505048A SE 8505048 A SE8505048 A SE 8505048A SE 8505048 D0 SE8505048 D0 SE 8505048D0
Authority
SE
Sweden
Prior art keywords
emulsion
transporting properties
nutrition emulsion
acid transporting
properties
Prior art date
Application number
SE8505048A
Other languages
English (en)
Other versions
SE8505048L (sv
Inventor
K A J Wretlind
S Ljungberg
I Hakansson
R I Jeppsson
B M Ajaxon
Original Assignee
Nutritional Int Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutritional Int Res Inst filed Critical Nutritional Int Res Inst
Priority to SE8505048A priority Critical patent/SE8505048L/sv
Publication of SE8505048D0 publication Critical patent/SE8505048D0/sv
Priority to EP86850373A priority patent/EP0220153B1/en
Priority to DE8686850373T priority patent/DE3680451D1/de
Priority to NO864269A priority patent/NO864269L/no
Priority to DK510486A priority patent/DK510486A/da
Publication of SE8505048L publication Critical patent/SE8505048L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8505048A 1985-10-25 1985-10-25 Nutritionsemulsion med syretransporterande egenskaper SE8505048L (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8505048A SE8505048L (sv) 1985-10-25 1985-10-25 Nutritionsemulsion med syretransporterande egenskaper
EP86850373A EP0220153B1 (en) 1985-10-25 1986-10-23 A nutritive emulsion having oxygen-transporting properties, and process for its preparation
DE8686850373T DE3680451D1 (de) 1985-10-25 1986-10-23 Naehremulsion mit sauerstoff transportierenden eigenschaften und verfahren zu ihrer herstellung.
NO864269A NO864269L (no) 1985-10-25 1986-10-24 Fremgangsmaate for fremstilling av en naeringsmiddelemulsjon
DK510486A DK510486A (da) 1985-10-25 1986-10-24 Oxygentransporterende, autoklaverbar naeringsemulsion og fremgangsmaade til fremstilling deraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505048A SE8505048L (sv) 1985-10-25 1985-10-25 Nutritionsemulsion med syretransporterande egenskaper

Publications (2)

Publication Number Publication Date
SE8505048D0 true SE8505048D0 (sv) 1985-10-25
SE8505048L SE8505048L (sv) 1987-04-26

Family

ID=20361921

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505048A SE8505048L (sv) 1985-10-25 1985-10-25 Nutritionsemulsion med syretransporterande egenskaper

Country Status (5)

Country Link
EP (1) EP0220153B1 (sv)
DE (1) DE3680451D1 (sv)
DK (1) DK510486A (sv)
NO (1) NO864269L (sv)
SE (1) SE8505048L (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931472A (en) * 1985-09-17 1990-06-05 Biomed Technology, Inc. Fluorinated triethylenediamine as an oxygen transport agent
US5077036A (en) * 1986-01-14 1991-12-31 Alliance Pharmaceutical Corp. Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
US5847009A (en) 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
EP0231091B1 (en) * 1986-01-24 1993-03-31 Children's Hospital Medical Center Stable emulsions of highly fluorinated organic compound
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
JP2644358B2 (ja) * 1990-03-15 1997-08-25 帝人株式会社 細胞の培養方法
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
FR2679788B1 (fr) * 1991-08-02 1994-03-18 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
US5304325A (en) * 1991-11-13 1994-04-19 Hemagen/Pfc Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
DE4338046A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung
US5733526A (en) * 1995-12-14 1998-03-31 Alliance Pharmaceutical Corp. Hydrocarbon oil/fluorochemical preparations and methods of use
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
AU2001276963A1 (en) * 2000-07-19 2002-01-30 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
JPS537492B2 (sv) * 1973-02-12 1978-03-18
JPS5331209B2 (sv) * 1973-10-05 1978-09-01
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
US4446154A (en) * 1982-03-03 1984-05-01 Thomas Jefferson University Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4423077A (en) * 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood

Also Published As

Publication number Publication date
DK510486A (da) 1987-04-26
DE3680451D1 (de) 1991-08-29
EP0220153B1 (en) 1991-07-24
DK510486D0 (da) 1986-10-24
NO864269D0 (no) 1986-10-24
SE8505048L (sv) 1987-04-26
EP0220153A1 (en) 1987-04-29
NO864269L (no) 1987-04-27

Similar Documents

Publication Publication Date Title
SE8505048D0 (sv) Nutritionsemulsion med syretransporterande egenskaper
ATE110531T1 (de) Hochsaures system enthaltende nahrungsformulierungen.
DE3782737T2 (de) Stabilisierung von wachstumshormonen.
SE8803141L (sv) Naeringsmedel foer maenniskor och djur
ATE209864T1 (de) Zusammensetzung zur behandlung von patienten mit lebererkrankungen
CA2334222A1 (en) Insulin supplemented infant formula
EP0203649A3 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
FI903761A0 (fi) Sileringskomposition.
DE68912589D1 (de) Mittel zur verbesserung des fettabbaus und verfahren zur verwendung.
PT77079B (de) Verwendung von waessrigen l-lysin-loesungen zur supplementierung von futtermitteln undustriell hergestellten mischfuttern mit l-lysin
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
ATE96846T1 (de) Verfahren zur herstellung von proteinhydrolysaten mit niedrigem gehalt an bitterstoffen.
NZ235297A (en) Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution
FR2597750B1 (fr) Solution aqueuse stable de sulfate de vincristine
DE69431617D1 (de) Tierfutterzusammensetzung
ES554162A0 (es) Un procedimiento para la preparacion de derivados aminoacidicos de l-fosfoserina.
DE69423623D1 (de) Aminosäureergänzung
JPS57102197A (en) Stabilizing method of oxidizable aniline color reagent

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8505048-2

Effective date: 19920501